Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06161077 · ClinicalTrials.gov registry record
Voice Quality Analysis of Patients With Laryngotracheal Stenosis
A clinical trial, sponsored by Johns Hopkins University.
- Not yet
- Registry status
- 100
- Enrollment target
NCT06161077: Clinical Trial study, sponsored by Johns Hopkins University.
NCT06161077 is a clinical trial that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06161077 has not yet begun recruiting, sponsored by Johns Hopkins University.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators previously demonstrated that voice changes are common in patients with Laryngotracheal Stenosis (LTS), and patients typically report an improvement in voice outcomes following endoscopic dilation. Recently, NIH based programs such as a Bridge to Artificial Intelligence (Bridge2AI) have highlighted the use of artificial intelligence to identify acoustic biomarkers of disease. Therefore, the investigators hypothesize that progression of LTS scar can be quantified using acoustic measurements and machine learning. The goal of this clinical trial is to remotely monitor patient voice quality in an effort to determine if regularly performed voice recordings can be used as a diagnostic tool in order to predict the need for dilation procedures. The investigators feel that successful use of remote voice recording technology with algorithmic analysis will improve patient quality of life.
Primary Outcome
To remotely assess voice quality of patients with idiopathic subglottic stenosis with VoiceLab automated voice analysis software both before and at regular intervals following dilation procedures
Interventions
- DIAGNOSTIC_TEST Voice Biomarker Screening Too
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-12-01 |
What is known before NCT06161077 opens enrollment
NCT06161077 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Voice Biomarker Screening Too is the first listed.
NCT06161077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06161077 about?
NCT06161077 is a clinical study titled "Voice Quality Analysis of Patients With Laryngotracheal Stenosis". The investigators previously demonstrated that voice changes are common in patients with Laryngotracheal Stenosis (LTS), and patients typically report an improvement in voice outcomes following endoscopic dilation. Recently, NIH based programs such as a Bridge to Artificial Intelligence (Bridge2AI) ...
What is the current status of trial NCT06161077?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-07-01. Estimated completion is 2028-12-01.
What interventions are being tested in trial NCT06161077?
The interventions under investigation include: Voice Biomarker Screening Too (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06161077?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI